Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 3
2017 7
2018 3
2019 3
2020 8
2021 5
2022 4
2023 5
2024 4
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.
Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, Fidelle M, Flament C, Poirier-Colame V, Opolon P, Klein C, Iribarren K, Mondragón L, Jacquelot N, Qu B, Ferrere G, Clémenson C, Mezquita L, Masip JR, Naltet C, Brosseau S, Kaderbhai C, Richard C, Rizvi H, Levenez F, Galleron N, Quinquis B, Pons N, Ryffel B, Minard-Colin V, Gonin P, Soria JC, Deutsch E, Loriot Y, Ghiringhelli F, Zalcman G, Goldwasser F, Escudier B, Hellmann MD, Eggermont A, Raoult D, Albiges L, Kroemer G, Zitvogel L. Routy B, et al. Among authors: naltet c. Science. 2018 Jan 5;359(6371):91-97. doi: 10.1126/science.aan3706. Epub 2017 Nov 2. Science. 2018. PMID: 29097494
Antecedent viral immunization and efficacy of immune checkpoint blockade: an extensive serum antibody profile to predict outcomes in non-small cell lung cancer.
Dall'Olio FG, Zrafi WS, Blampey Q, Danlos FX, Roulleaux-Dugage M, Roman G, Naltet C, Cournède PH, Gautheret D, Aldea M, Planchard D, Barlesi F, Marabelle A, Hulett T, Chaput-Gras N, Besse B. Dall'Olio FG, et al. Among authors: naltet c. J Immunother Cancer. 2024 Nov 28;12(11):e009931. doi: 10.1136/jitc-2024-009931. J Immunother Cancer. 2024. PMID: 39613338 Free PMC article.
Anti-ALK autoantibodies in patients with ALK-positive Non-Small Cell Lung Cancer (NSCLC): A monocentric experience.
Parisi C, Benitez JC, Lecourt H, dall'Olio FG, Aldea M, Blanc-Durand F, Vergé V, Quivoron C, Naltet C, Abdayem P, Lavaud P, Ghigna MR, Friboulet L, Loriot Y, De Botton S, Ribrag V, Ardizzoni A, Planchard D, Soria JC, Barlesi F, Besse B. Parisi C, et al. Among authors: naltet c. J Liq Biopsy. 2024 Jul 30;6:100164. doi: 10.1016/j.jlb.2024.100164. eCollection 2024 Dec. J Liq Biopsy. 2024. PMID: 40027306 Free PMC article.
A Patient-Centered Model of Fast-Track Lung Cancer Diagnosis.
Pradere P, Caramella C, Salem FB, Florea V, Crutu A, Hanna A, Mabille L, Kim YW, De Montpreville V, Feuillet S, Naltet C, Planchard D, Blanc E, Fadel E, Pavec JL, Mercier O. Pradere P, et al. Among authors: naltet c. Clin Lung Cancer. 2023 Jul;24(5):453-458. doi: 10.1016/j.cllc.2023.03.006. Epub 2023 Mar 20. Clin Lung Cancer. 2023. PMID: 37030992
Outcomes of extended resection for locally advanced thymic malignancies.
Menager JB, Mercier O, Levy A, Botticella A, Pradère P, Fabre D, Issard J, Naltet C, Planchard D, Barles F, De Montpreville V, Le Pechoux C, Besse B, Fadel E; for International Center for Thoracic Cancers (CICT) Rare Tumors Hub Working Group. Menager JB, et al. Among authors: naltet c. Respir Med Res. 2023 Jun;83:101009. doi: 10.1016/j.resmer.2023.101009. Epub 2023 Mar 23. Respir Med Res. 2023. PMID: 37087902
39 results